Travis W. Grim

1.4k total citations
19 papers, 504 citations indexed

About

Travis W. Grim is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Travis W. Grim has authored 19 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Travis W. Grim's work include Cannabis and Cannabinoid Research (11 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuropeptides and Animal Physiology (7 papers). Travis W. Grim is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuropeptides and Animal Physiology (7 papers). Travis W. Grim collaborates with scholars based in United States, China and Canada. Travis W. Grim's co-authors include Laura Bohn, Aron H. Lichtman, Benjamin F. Cravatt, Cullen L. Schmid, Rehab A. Abdullah, Nicole Kennedy, Thomas D. Bannister, Sudeshna Ghosh, Michael D. Cameron and Steven G. Kinsey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biological Psychiatry and The FASEB Journal.

In The Last Decade

Travis W. Grim

19 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Travis W. Grim United States	14	319	251	199	118	74	19	504
Carrie E. Wertheim United States	10	344 1.1×	248 1.0×	209 1.1×	79 0.7×	45 0.6×	10	467
Molly S. Crowe United States	11	218 0.7×	388 1.5×	170 0.9×	111 0.9×	66 0.9×	13	607
Paola Mascia Italy	11	393 1.2×	279 1.1×	242 1.2×	106 0.9×	26 0.4×	20	642
Steven J. R. Elmes United Kingdom	10	297 0.9×	382 1.5×	116 0.6×	295 2.5×	75 1.0×	12	607
D. Matthew Walentiny United States	14	410 1.3×	519 2.1×	159 0.8×	148 1.3×	122 1.6×	29	755
G. Patrick United States	7	239 0.7×	282 1.1×	113 0.6×	72 0.6×	72 1.0×	9	456
Maria De Chiaro Italy	11	202 0.6×	169 0.7×	150 0.8×	176 1.5×	21 0.3×	13	451
Fiona Templeton United Kingdom	3	187 0.6×	315 1.3×	86 0.4×	49 0.4×	33 0.4×	4	351
Anna Gołda Poland	10	404 1.3×	190 0.8×	146 0.7×	35 0.3×	32 0.4×	21	538
Gavin N. Petrie Canada	13	268 0.8×	429 1.7×	61 0.3×	75 0.6×	34 0.5×	25	543

Countries citing papers authored by Travis W. Grim

Since Specialization

Citations

This map shows the geographic impact of Travis W. Grim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travis W. Grim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travis W. Grim more than expected).

Fields of papers citing papers by Travis W. Grim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Travis W. Grim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travis W. Grim. The network helps show where Travis W. Grim may publish in the future.

Co-authorship network of co-authors of Travis W. Grim

This figure shows the co-authorship network connecting the top 25 collaborators of Travis W. Grim. A scholar is included among the top collaborators of Travis W. Grim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Travis W. Grim. Travis W. Grim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Grim, Travis W., Cullen L. Schmid, Edward L. Stahl, et al.. (2023). Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules. 13(6). 935–935. 4 indexed citations

Stahl, Edward L., Cullen L. Schmid, Cai Read, et al.. (2021). G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists. Proceedings of the National Academy of Sciences. 118(48). 23 indexed citations

Jiang, Shan, Christos Iliopoulos‐Tsoutsouvas, Fei Tong, et al.. (2021). Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists. Journal of Medicinal Chemistry. 64(7). 3870–3884. 14 indexed citations

Grim, Travis W., Cullen L. Schmid, Nicole Kennedy, et al.. (2020). Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain. Neuropharmacology. 185. 108439–108439. 20 indexed citations

Grim, Travis W., Cullen L. Schmid, Edward L. Stahl, et al.. (2019). A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal. Neuropsychopharmacology. 45(2). 416–425. 59 indexed citations

Grim, Travis W., et al.. (2019). Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics. Biological Psychiatry. 87(1). 15–21. 60 indexed citations

Laprairie, Robert B., Kiran Vemuri, Edward L. Stahl, et al.. (2019). Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist. Molecular Pharmacology. 96(5). 619–628. 4 indexed citations

Rice, Kenner C., Samuel Obeng, Yan Zhang, et al.. (2019). Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats. Neuropharmacology. 150. 200–209. 42 indexed citations

Grim, Travis W., Scarlet J. Park, Cullen L. Schmid, et al.. (2018). The effect of quinine in two bottle choice procedures in C57BL6 mice: Opioid preference, somatic withdrawal, and pharmacokinetic outcomes. Drug and Alcohol Dependence. 191. 195–202. 10 indexed citations

10.

Wilkerson, Jenny L., Giulia Donvito, Travis W. Grim, et al.. (2017). Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. Journal of Pharmacology and Experimental Therapeutics. 363(3). 394–401. 22 indexed citations

11.

Grim, Travis W., Arturo J. Morales, Brian F. Thomas, et al.. (2017). Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model. Journal of Pharmacology and Experimental Therapeutics. 362(1). 210–218. 18 indexed citations

12.

Grim, Travis W., Cullen L. Schmid, Robert B. Laprairie, et al.. (2017). Preference, dependence, and pharmacokinetic outcomes in an opioid two bottle choice paradigm. The FASEB Journal. 31(S1). 1 indexed citations

13.

Grim, Travis W., Bogna M. Ignatowska‐Jankowska, Tao Qing, et al.. (2016). Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497. Journal of Basic and Clinical Physiology and Pharmacology. 27(3). 217–228. 15 indexed citations

14.

Wilkerson, Jenny L., Micah J. Niphakis, Travis W. Grim, et al.. (2016). The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. Journal of Pharmacology and Experimental Therapeutics. 357(1). 145–156. 53 indexed citations

15.

Grim, Travis W., Arturo J. Morales, Jenny L. Wiley, et al.. (2016). Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays. Journal of Pharmacology and Experimental Therapeutics. 359(2). 329–339. 33 indexed citations

16.

Grim, Travis W., et al.. (2015). Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice. Drug and Alcohol Dependence. 150. 31–37. 13 indexed citations

17.

Ghosh, Sudeshna, Steven G. Kinsey, Qing-song Liu, et al.. (2015). Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. Journal of Pharmacology and Experimental Therapeutics. 354(2). 111–120. 39 indexed citations

18.

Grim, Travis W., Robert A. Owens, Matthew F. Lazenka, et al.. (2014). Δ9-Tetrahydrocannabinol and Endocannabinoid Degradative Enzyme Inhibitors Attenuate Intracranial Self-Stimulation in Mice. Journal of Pharmacology and Experimental Therapeutics. 352(2). 195–207. 32 indexed citations

19.

Grim, Travis W., Sudeshna Ghosh, Ku‐Lung Hsu, et al.. (2014). Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. Pharmacology Biochemistry and Behavior. 124. 405–411. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact